HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, W.-H. Articles by Hoffman, A. R. Search for Related Content PubMed PubMed Citation Articles by Wang, W.-H. Articles by Hoffman, A. R. Social Bookmarking                      What's this?

Volume 271, Number 44, Issue of November 1, 1996 pp. 27863-27870
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Increased Expression of the Insulin-like Growth Factor-II Gene in Wilms' Tumor Is Not Dependent on Loss of Genomic Imprinting or Loss of Heterozygosity

(Received for publication, June 3, 1996, and in revised form, July 26, 1996)

From the Medical Service and GRECC, Veterans Affairs Palo Alto Health Care System and Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304

Loss of imprinting of insulin-like growth factor-II gene (IGF2) and/or loss of heterozygosity at the 11p15 loci have been postulated to be responsible for IGF2 overexpression in Wilms' tumor. In order to delineate the mechanism of IGF2 overexpression in Wilms' tumors, we have genotyped the 11p15-11p13 chromosomal region and determined allelic expression of IGF2 and H19 in both tumor tissue and in normal adjacent kidney tissue from 40 patients with Wilms' tumor. In five of the eight subjects informative for the ApaI IGF2 polymorphism, loss of imprinting of IGF2 was observed in both normal and tumor tissues. A significant increase (>5-fold) in IGF2 expression in tumor tissues compared to the normal adjacent kidney tissue was observed regardless of the IGF2 imprinting or the chromosome 11p15 heterozygosity status. In each case, the overexpression of IGF2 in the tumors was accompanied by activation of all four IGF2 promoters. Our data indicate that alterations of IGF2 imprinting occurred in normal adjacent kidney tissue before tumorigenesis and that the IGF2 overexpression in Wilms' tumor tissue occurs through a loss of heterozygosity- or loss of imprinting-independent process.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. W. Brown, F. Power, B. Moore, A. K. Charles, and K. T.A. Malik Frequency and Timing of Loss of Imprinting at 11p13 and 11p15 in Wilms' Tumor Development Mol. Cancer Res., July 1, 2008; 6(7): 1114 - 1123. [Abstract] [Full Text] [PDF]

				H.-M. Byun, H.-L. Wong, E. A. Birnstein, E. M. Wolff, G. Liang, and A. S. Yang Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer Cancer Res., November 15, 2007; 67(22): 10753 - 10758. [Abstract] [Full Text] [PDF]

				R. A. Waterland, J.-R. Lin, C. A. Smith, and R. L. Jirtle Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus Hum. Mol. Genet., March 1, 2006; 15(5): 705 - 716. [Abstract] [Full Text] [PDF]

				K. Woodson, A. Flood, L. Green, J. A. Tangrea, J. Hanson, B. Cash, A. Schatzkin, and P. Schoenfeld Loss of Insulin-Like Growth Factor-II Imprinting and the Presence of Screen-Detected Colorectal Adenomas in Women J Natl Cancer Inst, March 3, 2004; 96(5): 407 - 410. [Abstract] [Full Text] [PDF]

				T. H. Vu, N. V. Chuyen, T. Li, and A. R. Hoffman Loss of Imprinting of IGF2 Sense and Antisense Transcripts in Wilms' Tumor Cancer Res., April 15, 2003; 63(8): 1900 - 1905. [Abstract] [Full Text] [PDF]

				G. A. Ulaner, T. H. Vu, T. Li, J.-F. Hu, X.-M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi, et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site Hum. Mol. Genet., March 1, 2003; 12(5): 535 - 549. [Abstract] [Full Text] [PDF]

				I. M. Morison, D. M.O. Becroft, and A. E. Reeve Re: Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor J Natl Cancer Inst, December 4, 2002; 94(23): 1809 - 1809. [Full Text] [PDF]

				J. D. Ravenel, E. J. Perlman, K. W. Broman, and A. P. Feinberg RESPONSE: Re: Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor J Natl Cancer Inst, December 4, 2002; 94(23): 1809 - 1810. [Full Text] [PDF]

				C. Schwienbacher, A. Angioni, R. Scelfo, A. Veronese, G. A. Calin, G. Massazza, I. Hatada, G. Barbanti-Brodano, and M. Negrini Abnormal RNA Expression of 11p15 Imprinted Genes and Kidney Developmental Genes in Wilms' Tumor Cancer Res., March 1, 2000; 60(6): 1521 - 1525. [Abstract] [Full Text]

				E. W. Humke, J. Ni, and V. M. Dixit ERICE, a Novel FLICE-activatable Caspase J. Biol. Chem., June 19, 1998; 273(25): 15702 - 15707. [Abstract] [Full Text] [PDF]